Our Mission
CAMP4 Therapeutics is a clinical-stage biotechnology company harnessing the power of RNA to address genetic diseases characterized by decreased protein expression. CAMP4’s RAP platform™ enables the mapping of regulatory RNA (regRNA) sequences that function as master regulators of gene expression and the design of programmable therapeutic ASO candidates targeting these regRNAs. Founded by academic experts in the field of gene regulation and genetic diseases, CAMP4 is on a journey to chart new therapeutic territories and help patients reach new heights.